Key result
Circulating lipidomic profiles strongly distinguish severe obesity from non-obese controls with an AUC of ~0.90.
Why the study?
Severe obesity (BMI ≥ 40 kg/m2) is rising globally yet remains understudied mechanistically at the lipidomic species level.
Does circulating plasma lipidomic profiling distinguish severe obesity (BMI ≥ 40 kg/m²) from normal weight and identify potentially causal lipid species in Mexican American adults?
Cross-Sectional (n=578)
No
Does circulating plasma lipidomic profiling distinguish severe obesity (BMI ≥ 40 kg/m²) from normal weight and identify potentially causal lipid species in Mexican American adults?
Severe obesity in Mexican American adults is characterized by widespread circulating lipidome dysregulation—particularly elevated shorter-chain saturated and monounsaturated triacylglycerols that show a potential causal link to severe obesity and correlate with insulin resistance, visceral adiposity, and hepatic steatosis.
Answers are grounded in this paper and cite their sources.
Lipidomics may distinguish severe obesity; leaves open causal species and clinical utility pending prospective validation.
Severe obesity (SevO; BMI ≥ 40 kg/m 2 ) is rising globally yet remains understudied mechanistically. To characterize lipidomic alterations at the species level, we analyzed Border Health Research Cohort participants with fasting plasma lipidomics and genetic data, comparing SevO ( n = 185) to non-obese controls (18.5 ≥ BMI < 25; n = 393). We quantified 830 lipid species across 49 classes and assessed associations using logistic regression, orthogonal projections to latent structures discriminant analysis (OPLS-DA), and network deconvolution Mendelian randomization (NDMR). SevO participants showed more adverse cardiometabolic traits. Lipidomics revealed broad dysregulation: shorter, saturated, and monounsaturated triacylglycerols were elevated in individuals living with SevO compared to controls, while lysophospholipids, plasmalogens, cholesteryl esters, and long-chain species were reduced. OPLS-DA identified over 300 lipids strongly predictive of SevO, and NDMR implicated specific triacylglycerols as potentially contributing to SevO status. Influential lipids correlated with insulin resistance, liver fat, body composition, and high-density lipoprotein cholesterol (HDL-C). Short-chain triacylglycerols emerged as a distinctive, consistently elevated SevO signature.
No takes yet. Share an insight, caveat, or question.
Anwar et al. (2026) conducted a cross-sectional in Severe obesity (BMI ≥ 40 kg/m²) (n=578). Circulating plasma lipidome profile (830 lipid species across 49 classes) vs. Non-obese controls (18.5 ≤ BMI < 25 kg/m², n=393) was evaluated on Severe obesity status (BMI ≥ 40 kg/m² vs. 18.5 ≤ BMI < 25 kg/m²) and discriminative performance of the circulating lipidome (AUC 0.90, p=<0.05 (FDR-corrected)). Circulating lipidomic profiles strongly distinguished severe obesity from non-obese controls, with 222 overabundant and 362 underabundant lipid species.
Synapse has enriched 10 related papers. Consider them for comparative context: